We would love to hear your thoughts about our site and services, please take our survey here.
I'd sold down to my last £40K of Futura , but after the last few months of deja vu I've flogged the rest. To people who have been invested for more than a couple of years you'll have seen it all before, crappy alliances with companies you never heard of, products that get delayed and delayed, launches that go off like a damp squib. Now trying to take on generic cialis / viagra etc with a gel of doubtful efficacy and no marketing budget.
Not a chance.
So glad I topped up at 10 so have a good average price .Happy I managed to make a reasonable wedge - though to be fair if I'd shoved it in a decent fund all those years ago I'd probably have been ahead.
@LB keep up the good work in pointing out the emperors clothes, though if you are above water you should bale out and not waste your time cos most on this board have fingers in their ears and don't want to listen.
I had just under £200K , flogged a load at 55p got another £45K left. TBH I think this is going to be a real grind. We're not sure we can prove real world effectiveness and we're up against generic cialis and viagra at 50p-£2 a pop. Fannying around with companies you've never heard of before to do regional deals without big up front payments fills me with zero confidence.
There could be an addressable market for people taking nitrates IF we can prove effectiveness but we still have to work with a big company with pots of cash to get it launched effectively.
I'm sticking in a limit order , see if I can catch the next ripple to bail out on.
I agree with the Italian, If you think you are going to last to a ripe old age then pay the money now. Governments of any party tend to steer away from reducing the state pension because codgers tend to vote unlike the youngsters.
As a LTH (2014) who's still got 100K shares I don't mind a contrary view - better than sunshine and unicorns "fill your boots " chat.
We've still got a way to go to get revenue flowing (the cost of building a consumer brand is massive ) and we've all been burnt by the failures in the past. You've also got to consider the punter - would you rather spend £3 on a generic Cialis (which has the billions of marketing spend already spent so you are already familiar with) which you can take the day before so your partner doesn't know you've got a ED issue or get the gel out when you want to get busy? It's not a shoe in....
To be fair I haven't seen Liam ranting. He's providing a bit of a cold shower to those who are very bullish which seems to provoke ranting in others.
Xenor,
Futura is like that, long term holders have been 80p - 8p and back so have got used to it...
AKHM,
Remember Viagra was a drug meant for hypertension that had odd side effects....
Does anyone have an idea if this is OTC in Pharmacy only or can be sold in supermarkets etc? That will make a big difference to the uptake.
Hedgy,
Not sure why you are taking this so personally.
All drugs have side effects. The viagra info hasn't stopped their sales. The only relevance for Eroxon is how doctors can be persuaded to use it for patients who are contraindicated for Viagra because they take nitrates.
As I've said before , they key to success will be how much Futura's partner with can throw at the sales and marketing and if the product works in real life so that users re-buy and tell their mates.
That was odd, got posted twice.
Hedgy,
I'm not lecturing, I just don't think that banging on about Viagra side effects is very productive.
https://www.psychologytoday.com/us/blog/all-about-sex/201412/warning-men-erection-drugs-just-might-kill-you
1800 deaths possibly related from over 5 million users doesn't seem a whole lot and certainly hasn't affected sales.
I've still got 100K shares in Futura as I'm gambling that they finally get it right, but I sold the rest so I can retire in Feb rather than in 4 years time.
I work in the pharma industry so I know what it takes to launch a successful product and it costs an absolute fortune and a lot of launches don't succeed so don't think just because Eroxon has a better safety profile it's a guaranteed success.
Hedgy,
I'm not lecturing, I just don't think that banging on about Viagra side effects is very productive.
https://www.psychologytoday.com/us/blog/all-about-sex/201412/warning-men-erection-drugs-just-might-kill-you
1800 deaths possibly related from over 5 million users doesn't seem a whole lot and certainly hasn't affected sales.
I've still got 100K shares in Futura as I'm gambling that they finally get it right, but I sold the rest so I can retire in Feb rather than in 4 years time.
I work in the pharma industry so I know what it takes to launch a successful product and it costs an absolute fortune and a lot of launches don't succeed so don't think just because Eroxon has a better safety profile it's a guaranteed success.
Hedgy.
I think we can stop with the Viagra safety issue. All products have a wide a varied list of possible side effects. It's been used by millions of men over a long period without a significant number of people being negatively impacted.
This specific issues of melanoma can be explained - causation / correlation. Old people have more ED . Old people get more melanoma.
Eroxon will take off it gets a big marketing spend, if users like the quick mode of action and if it actually works in real life so that users re-buy and tell their mates.
LBO is blowing smoke about the potential safety issues with Eroxon , I don't think we need to fight fire with fire.
Wilco - exactly. they are a branded generic so they have to show some differentiation ( mode of delivery - chewy rather than pill ) and it's mainly way they are selling it - Loads of marketing spend and a inertia sell ( looks like you get a pack of pills a month unless you cancel) .
Wilco - I'm sure the pill packaging must use components or contain excipients that already approved by the FDA so combined with an approved generic they would just need to get a registration dossier approved to show they can provide the product to standard.
As they are loads of ED "products" with no clinical trail backup , Futura are seeking to differentiate by having medical device status hence why they are waiting for approval.
@ LBO
But healthcare professionals need to be made aware of the availability of the special product and need to be reminded. It takes anywhere from 4-8 sales interactions before an HCP changes how they prescribe, some won't do it unless a colleague has prescribed a new medicine and had decent patient feedback.
This is not a cheap process , that's why sales and marketing expenses are a big part of pharma companies balance sheets. I guess Futura made the decision that the revenue from specials wouldn't be worth the sales and marketing expense.
Sorry they are branded generic Viagra and Cialis . We are selling Eroxon as a medical device so need FDA approval.
These are just generic Viagra.
Hi Reflex, I'd planned to retire in 4/5 years but will probably do so in 18 months now. The better half suggested I sell some when it went to 80p 4 years or so ago and I didn't , so hence the de risk (would never hear the end of it...). I'm still hopeful that we can finally achieve lift off but the the level of investment required to properly launch an OTC brand is scary.
To be fair its working on me. The recent jump in price ( I was in at average 24p with 360K shares) has brought forward my retirement plans by a couple of years. LBO reminding me of the condom failure has prompted me to de-risk so I've flogged a load today, still got over 100K left , fingers crossed we get a good partnership announcement soon.